| Name | 3-ethyl-2-methoxy-6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine |
|---|---|
| Synonyms |
3-ethyl-2-methoxy-6-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]-dioxaborolan-2-yl)pyridine
D-1909 |
| Molecular Formula | C15H24BNO3 |
|---|---|
| Molecular Weight | 277.16700 |
| Exact Mass | 277.18500 |
| PSA | 40.58000 |
| LogP | 2.26020 |
|
~80%
867006-28-8 |
| Literature: AVENTIS PHARMACEUTICALS INC. Patent: WO2005/97750 A1, 2005 ; Location in patent: Page/Page column 59-60; 105 ; WO 2005/097750 A1 |
|
~75%
867006-28-8 |
| Literature: AVENTIS PHARMACEUTICALS INC. Patent: WO2005/97750 A1, 2005 ; Location in patent: Page/Page column 59 ; WO 2005/097750 A1 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |